MRM Medirom Healthcare Technologies Inc. Annual reports only
Services-Personal Services · Nasdaq · SEC CIK 1819704 · Reporting currency JPY · Fiscal year ends 12/31
Financial factors as of 2024-12-31 (FY2024), by fiscal year; growth vs the previous fiscal year
Growth
TTM revenue YoY21.5%
TTM net income YoY28.9%
TTM EPS YoY27.7%
Revenue 3-yr CAGR15.3%
Net income 3-yr CAGR—
Margins
Gross margin27.1%
Operating margin-0.2%
Net margin1.8%
FCF margin-16.9%
EBITDA margin3.3%
Returns
ROE26.0%
ROA2.0%
ROIC (approx.)-1.1%
Asset turnover1.11x
Leverage & solvency
Liabilities / assets85.3%
Debt / equity1.48x
Current ratio0.65x
Interest coverage-0.36x
Cash quality & payout
Operating cash flow / net income-8.95x
Accruals ratio19.8%
Payout ratio—
Capex / revenue0.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Unit: JPY | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 | FY20202020-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | 8.30B | 6.83B | 6.95B | 5.41B | 3.34B |
| Cost of revenue | 6.05B | 5.26B | 5.05B | — | — |
| Gross profit | 2.25B | 1.57B | 1.90B | — | — |
| SG&A expense | 2.24B | 1.96B | 1.81B | 1.82B | 1.07B |
| Operating income | -18.10M | -391.58M | 96.97M | -470.59M | -746.09M |
| Interest expense | 49.74M | 36.87M | 9.80M | 11.95M | 13.23M |
| Pretax income | 47.71M | 20.62M | 179.77M | -414.48M | -626.69M |
| Income tax | -90.48M | -94.43M | 30.81M | 576.25M | -87.52M |
| Net income | 148.76M | 115.40M | 148.97M | -990.73M | -539.17M |
| EBITDA | 271.94M | -138.98M | 281.02M | -344.34M | -683.80M |
| EPS (basic) | 29.13 | 23.64 | 30.54 | -203.13 | -133.97 |
| EPS (diluted) | 28.52 | 22.34 | 27.23 | -203.13 | -133.97 |
| Weighted avg. shares (diluted) | 5.85M | 5.17M | 5.47M | 4.88M | 4.02M |
| Balance sheet | |||||
| Cash & equivalents | 329.40M | 106.35M | 605.45M | 370.62M | 1.44B |
| Short-term investments | 6.16M | 26.50M | 26.50M | 26.53M | 32.52M |
| Receivables | 1.36B | 621.87M | 534.69M | 312.30M | 148.54M |
| Inventory | 151.64M | 139.98M | 114.11M | 18.70M | 7.96M |
| Current assets | 2.71B | 1.76B | 2.36B | 1.38B | 2.09B |
| PP&E, net | 435.66M | 451.50M | 424.29M | 425.00M | 235.93M |
| Goodwill | 389.13M | 484.56M | 539.49M | 600.33M | 150.72M |
| Intangibles | 1.14B | 920.70M | 403.67M | 391.04M | 97.61M |
| Total assets | 8.09B | 6.85B | 6.75B | 5.75B | 5.71B |
| Current liabilities | 4.18B | 3.56B | 3.64B | 3.20B | 2.65B |
| Short-term debt | 620.81M | 100.42M | 99.17M | 162.25M | 242.28M |
| Long-term debt | 764.20M | 1.05B | 1.15B | 746.59M | 668.38M |
| Total debt | 1.39B | 1.15B | 1.25B | 908.84M | 910.66M |
| Total liabilities | 6.90B | 6.63B | 6.81B | 5.96B | 5.22B |
| Shareholders' equity | 933.27M | 210.88M | -59.38M | -208.34M | 491.26M |
| Net debt | 1.06B | 1.04B | 643.48M | 538.22M | -529.07M |
| Shares outstanding | 7.90M | — | — | — | — |
| Cash flow statement | |||||
| Operating cash flow | -1.33B | -631.74M | -685.70M | -557.23M | -366.42M |
| Capital expenditure | 71.41M | 135.84M | 120.74M | 95.65M | 73.56M |
| Free cash flow | -1.40B | -767.58M | -806.44M | -652.88M | -439.98M |
| Investing cash flow | 361.39M | -328.58M | 580.44M | -83.94M | -139.60M |
| Financing cash flow | 1.19B | 461.21M | 340.10M | -427.95M | 1.43B |
| Depreciation & amortization | 290.04M | 252.59M | 184.06M | 126.24M | 62.29M |
| Stock-based compensation | — | — | — | 196.85M | — |
Free plan shows the latest 5 periods; Pro shows all 6 🔒
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· Amounts are in the company's reporting currency, JPY, not USD; the site does no currency conversion.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.